Zobrazeno 1 - 10
of 46
pro vyhledávání: '"James G. Kublin"'
Autor:
Maurine D Miner, Mark Hatherill, Vidya Mave, Glenda E Gray, Sharon Nachman, Sarah W Read, Richard G White, Anneke Hesseling, Frank Cobelens, Sheral Patel, Mike Frick, Theodore Bailey, Robert Seder, Joanne Flynn, Jyothi Rengarajan, Deepak Kaushal, Willem Hanekom, Alexander C Schmidt, Thomas J Scriba, Elisa Nemes, Erica Andersen-Nissen, Alan Landay, Susan E Dorman, Grace Aldrovandi, Lisa M Cranmer, Cheryl L Day, Alberto L Garcia-Basteiro, Andrew Fiore-Gartland, Robin Mogg, James G Kublin, Amita Gupta, Gavin Churchyard
Publikováno v:
The lancet. HIV. 9(11)
New tuberculosis vaccine candidates that are in the development pipeline need to be studied in people with HIV, who are at high risk of acquiring Mycobacterium tuberculosis infection and tuberculosis disease and tend to develop less robust vaccine-in
Autor:
Srilatha Edupuganti, Maria G. Pau, Magda Sobieszczyk, Merlin L. Robb, Johannes P. M. Langedijk, M. Juliana McElrath, Lorenz Scheppler, Michal Sarnecki, Susan Buchbinder, Dan H. Barouch, Ian Frank, Kristen W. Cohen, Joseph P. Nkolola, Stephen R. Walsh, Etienne Karita, Hong Van Tieu, Lawrence Corey, Julie A Ake, Guido Ferrari, Steven Nijs, Kenneth H. Mayer, Karen Buleza, Lindsey R. Baden, Katleen Callewaert, Nadine Rouphael, Galit Alter, Georgia D. Tomaras, Paul A. Goepfert, Dimitri Goedhart, Frank Wegmann, Colleen Kelly, James G. Kublin, Lauren Peter, Trevor A Crowell, David C. Montefiori, Frank Tomaka, Philipp Mann, Michael C. Keefer, Daniel J. Stieh, Zelda Euler, Hanneke Schuitemaker
Publikováno v:
The Lancet. HIV
Summary Background Bioinformatically designed mosaic antigens increase the breadth of HIV vaccine-elicited immunity. This study compared the safety, tolerability, and immunogenicity of a newly developed, tetravalent Ad26 vaccine with the previously t
Autor:
Shirley Galbiati, Jessie K. Kennedy, Thomas L. Richie, Stephen L. Hoffman, Natasha Kc, Lisa A. Jackson, Sumana Chakravarty, Eric R. James, Yonas Abebe, B. Kim Lee Sim, James G. Kublin, Sean C. Murphy, Kristen W. Cohen, Gregory A. Deye
Publikováno v:
PLoS Pathogens, Vol 17, Iss 5, p e1009594 (2021)
PLoS Pathogens
PLoS Pathogens
PfSPZ-CVac combines ‘PfSPZ Challenge’, which consists of infectious Plasmodium falciparum sporozoites (PfSPZ), with concurrent antimalarial chemoprophylaxis. In a previously-published PfSPZ-CVac study, three doses of 5.12x104 PfSPZ-CVac given 28
Autor:
James G. Kublin
Publikováno v:
Journal of the International AIDS Society
Autor:
Maphoshane Nchabeleng, Fatima Laher, Glenda Gray, Linda-Gail Bekker, Gavin J. Churchyard, Koleka Mlisana, Rephaim Mpofu, Mary Allen, James G. Kublin, Kennedy Otwombe, M. Juliana McElrath
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0241708 (2021)
PLoS ONE
PLoS ONE
Benign ethnic neutropenia (BEN) is defined as a neutrophil count of 9 cells/L in healthy individuals and is more common in populations of certain ethnicities, e.g. African or Middle Eastern ethnicity. Neutrophil values are commonly included in eligib
Autor:
Lamar Ballweber Fleming, Craig Innes, Valentin Voillet, Lindsay N. Carpp, Anneta F Naidoo, M. Juliana McElrath, Peter B. Gilbert, Glenda Gray, Guido Ferrari, Nicole Grunenberg, Linda-Gail Bekker, Fatima Laher, Georgia D. Tomaras, Erica Andersen-Nissen, James G. Kublin, Ying Huang, Andrew Fiore-Gartland, Michael S. Harper
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 17, Iss 3, p e1009363 (2021)
PLoS Pathogens, Vol 17, Iss 3, p e1009363 (2021)
The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to prevent HIV-1 infection. Subsequent analyses identified antibody and cellular immune responses as correlates of risk (CoRs) for HIV infection. Early predic
Autor:
Andrew Fiore-Gartland, James G. Kublin, Giuseppe Pantaleo, Shelly Karuna, Jacob A. Cram, Sujatha Srinivasan, David N. Fredricks, Georgia D. Tomaras
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0225622 (2019)
PLoS ONE, Vol 14, Iss 12, p e0225622 (2019)
Antibodies that recognize commensal microbial antigens may be cross reactive with a part of the human immunodeficiency virus (HIV) envelope glycoprotein gp41. To improve understanding of the role of the microbiota in modulating the immune response to
Autor:
Allan C. deCamp, Mary Allen, James G. Kublin, M. Juliana McElrath, Mina C. Hosseinipour, Craig Innes, Zoe Moodie, Giuseppe Pantaleo, Jack Heptinstall, Chenchen Yu, Nonhlanhla N. Mkhize, Nicole Frahm, Peter B. Gilbert, Erica Andersen-Nissen, Maurine D. Miner, Linda-Gail Bekker, Fatima Laher, Sarita Naidoo, Glenda Gray, Kristen W. Cohen, Julia Hutter, Hvtn trial teams, Philipp Mann, Lucas Maganga, David C. Montefiori, Lynn Morris, Ralf Wagner, One Dintwe, Georgia D. Tomaras, Nicole L. Yates, Nicole Grunenberg, Stephen R. Walsh, Michael E Herce
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 5, p e1003117 (2020)
PLoS Medicine, Vol 17, Iss 5, p e1003117 (2020)
Background DNA plasmids promise a pragmatic alternative to viral vectors for prime-boost HIV-1 vaccines. We evaluated DNA plasmid versus canarypox virus (ALVAC) primes in 2 randomized, double-blind, placebo-controlled trials in southern Africa with h
Autor:
Mina C, Hosseinipour, Craig, Innes, Sarita, Naidoo, Philipp, Mann, Julia, Hutter, Gita, Ramjee, Modulakgotla, Sebe, Lucas, Maganga, Michael E, Herce, Allan C, deCamp, Kyle, Marshall, One, Dintwe, Erica, Andersen-Nissen, Georgia D, Tomaras, Nonhlanhla, Mkhize, Lynn, Morris, Ryan, Jensen, Maurine D, Miner, Giuseppe, Pantaleo, Song, Ding, Olivier, Van Der Meeren, Susan W, Barnett, M Juliana, McElrath, Lawrence, Corey, James G, Kublin, Daryl, Morris
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The Pox-Protein Public-Private Partnership is performing a suite of trials to evaluate the bivalent subtype C envelope protein (TV1.C and 1086.C glycoprotein 120) vaccine in the context of different adjuvants and priming agents for human i
Autor:
Michele P. Andrasik, Richa Chaturvedi, Linda Oseso, Stephaun E. Wallace, James G. Kublin, Jonathan Lucas, Sally Bock, David R. Wilson, Nelson L. Michael, Chris Beyrer, Gail Broder, George A. Mensah, Jasmin Aina
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258858 (2021)
PLoS ONE
PLoS ONE
Longstanding social and economic inequities elevate health risks and vulnerabilities for Black, Indigenous and People of Color (BIPOC) communities. Engagement of BIPOC communities in infectious disease research is a critical component in efforts to i